Noriyuki Kawamoto

This inventor holds 5 USPTO granted patents. Top assignees: Ss Pharmaceutical Co., Ltd., Ssp Co. Ltd, Hisamitsu Medical Co., Ltd.. Active years: 1999-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Kawamoto. Retrieved from https://idiyas.com/inventor/noriyuki-kawamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Narita, JP (1999 - 2002)
Chiba, JP (2005)

Company Filing History:

2 out of 90

Ss Pharmaceutical Co., Ltd.

Hisamitsu Medical Co., Ltd.

patent

Years Active: 1999-2005

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6958353 - Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts (2005-10-25),

2. 6362203 - 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same (2002-03-26),

3. 6071943 - Imidazole derivative and medicine comprising the same as active (2000-06-06),

4. 6046218 - Pyridine derivative and medicament containing the same as an effective (2000-04-04),

5. 5935977 - Substituted vinyl pyridine derivative and drugs containing the same (1999-08-10),

Title: Noriyuki Kawamoto: A Pioneer in Pharmaceutical Innovations

Introduction

Noriyuki Kawamoto, an accomplished inventor based in Narita, Japan, has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Kawamoto's work focuses primarily on innovative chemical compounds and their therapeutic applications.

Latest Patents

Kawamoto's recent patents include notable inventions such as imidazole derivatives or salts thereof, which are aimed at developing novel drugs. His invention features an imidazole derivative represented by a specific formula, where various substituents greatly influence the compound’s characteristics. These compounds demonstrate excellent effects in inhibiting the production of nitric oxide (NO) and interleukin-6 (IL-6), making them valuable in preventing or treating diseases caused by their overproduction. Another patent involves 4-hydroxy-4-phenylpiperidine derivatives and the pharmaceuticals that contain them, further showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Noriyuki Kawamoto has been associated with esteemed companies such as SSP Co. Ltd and SS Pharmaceutical Co., Ltd. His innovative approach to drug development has significantly impacted the pharmaceutical industry and contributed to the advancement of medical treatments.

Collaborations

Kawamoto has collaborated with several talented individuals, including coworkers Susumu Sato and Kazuo Yamazaki. These collaborations have led to the development of groundbreaking pharmaceutical compounds, enhancing the effectiveness of treatments available in the market today.

Conclusion

Noriyuki Kawamoto stands out as a notable inventor in the realm of pharmaceutical innovations. With a strong portfolio of patents and collaborative efforts, he continues to make strides in developing therapies that address critical health challenges, particularly those arising from the overproduction of harmful substances in the body. His work exemplifies the intersection of creativity and scientific inquiry in the pursuit of better health solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]